Market News AIOpen the app

RBC Capital Markets increased its price target for Doximity, Inc. from $28 to $34.

OpinionRead the original at marketscreener.com
Good for DOCS

Doximity received a higher price target from RBC, which kept its Outperform rating. That is a favorable analyst view, but the report gives no new company results.

DOCS · Doximity, Inc.

AI read · Good for DOCS

The AI's read

This gives investors a more favorable outside view of Doximity's prospects. The report offers no new sales, profit, or product information, so the positive read rests only on RBC's assessment.

Get alerts for DOCS

Follow Doximity, Inc. (DOCS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for DOCS
Free on the App Store and Google Play, or on the web.